President Trump is revisiting one of the signature health policies of his first administration: making health care prices public. It hasn’t gone smoothly. Now Trump is calling for new rules and more public prices to deliver on his goal of a more competitive — less costly — health care market.
Prescription Drugs
Posted inInsurance
Everyone’s Mad at Health Insurers, But ‘There’s Plenty of Blame to Go Around’
The murder of UnitedHealthcare’s CEO has put health insurance companies in the spotlight. But insurers are just one piece of America’s broken and expensive health care system.
Posted inHealth Law
Health Policy on the Ballot
Learn more about where President-elect Donald Trump stands on critical health policy issues.
Posted inInsurance
How Did Picking a Medicare Plan Get So Hard?
Medicare’s open enrollment season presents a challenging choice for its 67 million beneficiaries: selecting a new plan.
Posted inHealth Law
3 Health Care Decisions Awaiting the Next President
The next U.S. president will have to make consequential choices about the Affordable Care Act, prescription drug prices and abortion.
Posted inCost of Care
Race to the Bottom: Where’s the Cavalry?
Some of the most powerful new medicines pose a host of challenges for drug companies trying to copy and sell similar versions on the cheap. Can those companies find a sustainable path forward, or will patients get left stuck paying exorbitant prices?
Posted inCost of Care
3 Big Threats to the Cheap, Effective Medicines That Underpin U.S. Health Care
The U.S. has relied on cheap, effective generic drugs for 40 years. Now that promise is under threat.
Posted inCost of Care
Race to the Bottom: Hard Bargain
America pays less, on average, than any other major country for our generic drugs. But selling essential medicines at such low prices comes with hidden costs — from quality problems to frequent shortages.
Posted inCost of Care
Race to the Bottom: Boom Times
In this first part of our three-part series “Race to the Bottom,” we trace the origins of America’s generic drug industry — groundbreaking, bipartisan legislation signed by President Ronald Reagan that saved us trillions and also got us into trouble.
Posted inNews & Announcements
“Race to the Bottom”: A New Series from Tradeoffs on the Ailing Generic Drug Industry
Debuting Sept. 12, this three-part series examines the problems plaguing an industry that America now relies on to fill 9 out of every 10 prescriptions.